Key result
Transabdominal small-incision off-pump right gastroepiploic artery bypass achieves 3-month graft patency in initial cases.
Why the study?
Does simple transabdominal minimally invasive direct coronary artery bypass surgery with right gastroepiploic artery provide safe and effective revascularization in patients with isolated right coronary artery disease?
Case Report (n=3)
Does simple transabdominal minimally invasive direct coronary artery bypass surgery with right gastroepiploic artery provide safe and effective revascularization in patients with isolated right coronary artery disease?
Transabdominal minimally invasive direct coronary artery bypass surgery with the right gastroepiploic artery is a feasible and safe approach for isolated right coronary artery disease, avoiding thoracotomy.
May support feasibility of transabdominal RGEA grafting for isolated RCA disease; leaves open need for larger prospective studies.
For three patients with isolated right coronary artery disease who had drug resistance and were intolerant to interventional therapy, simple transabdominal small incision bypass grafting of the right gastroepiploic artery and the posterior descending branch of the right coronary artery was conducted without cardiopulmonary. All three patients were discharged smoothly without complications, and were followed up for three months, during which time the myocardial bridges were unobstructed and the cardiac functions were good. The surgery needs no thoracotomy and the injury is small, and avoids influences of sternum and pericardium adhesion on other cardiac surgery in the future. The risk of median sternotomy can be avoided for patients undergoing reoperation for coronary artery bypass surgery.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) conducted a case report in Isolated right coronary artery disease (n=3). Simple transabdominal small incision bypass grafting of the right gastroepiploic artery and the posterior descending branch of the right coronary artery without cardiopulmonary bypass was evaluated on Discharge status, complications, graft patency, and cardiac function at 3 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: